查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999332

胶囊内视镜市场：2026-2032年全球市场预测（依产品类型、内视镜模式、年龄层、应用程式、通路和最终用户划分）

Capsule Endoscopy Market by Product Type, Endoscopy Mode, Age Group, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胶囊内视镜市场价值将达到 5.4109 亿美元，到 2026 年将成长至 5.8389 亿美元，到 2032 年将达到 9.4449 亿美元，复合年增长率为 8.28%。

主要市场统计数据
基准年 2025 5.4109亿美元
预计年份：2026年 5.8389亿美元
预测年份 2032 9.4449亿美元
复合年增长率 (%) 8.28%

探索胶囊内视镜技术在重新定义非侵入性胃肠道诊断以改善患者预后的变革性作用。

胶囊内视镜彻底革新了胃肠道诊断，它以一个可吞嚥的胶囊取代了传统的侵入性内视镜检查。这种胶囊体积小巧，内建高解析度成像感测器，使临床医生能够以前所未有的方式观察以往难以成像的小肠区域。因此，与传统内视镜检查相比，患者的不适感和风险都大大降低，从而提高了需要定期进行胃肠道检查的患者的就诊率。

识别塑造胶囊内视镜未来发展的关键技术和监管变革，并推动全球胃肠道成像领域的创新。

技术突破正推动胶囊内视镜领域发生前所未有的变革，模糊了诊断与数据驱动决策之间的界线。近期推出的超高解析度成像晶片带来了前所未有的清晰度，能够侦测到以往无法察觉的微小黏膜病变。同时，电源管理技术的进步延长了胶囊电池的使用寿命，使其能够更长时间地通过消化道，从而确保从食道到结肠的全面可视化。

评估 2025 年美国关税调整对全球胶囊内视镜供应链和市场动态的累积影响。

2025年，美国关税调整的实施将为胶囊内视镜供应链带来新的挑战，迫使相关人员重新评估筹资策略和成本结构。传统上依赖从主要製造地进口零件的设备製造商，如今正面临专用成像感测器、微型电池单元和无线传输模组等零件关税上涨的困境。因此，生产成本不断攀升，迫使製造商寻求替代供应商并建立策略伙伴关係，以缓解关税带来的价格压力。

关键细分见解，包括产品变体、内视镜模式、年龄层、临床应用、分销管道和最终用户类别。

详细的細項分析揭示了不同产品配置和临床背景如何影响市场接受度的明显趋势。例如，结肠胶囊内视镜系统因其专为结肠评估而设计而备受关注，而食道和小肠平台则针对特定的诊断场景。每个产品层级都展现出独特的性能特征，从针对食道通过而优化的胶囊尺寸到专为小肠成像设计的高级光学涂层，不一而足。

分析美洲、欧洲、中东和非洲以及亚太市场引入胶囊内视镜的区域趋势和成长要素。

在整个美洲，尤其是在北美市场，对胃肠道诊断基础设施的投资正在加速成长，胶囊内视镜作为一种首选的非侵入性检查方式正日益普及。有利的保险报销政策和较高的结直肠癌筛检计画覆盖率正鼓励临床医生将胶囊内视镜系统纳入其常规通讯协定。在拉丁美洲，不断增长的医疗保健预算和公共卫生倡议也促进了胶囊内视镜的普及，儘管各国在成本考量和监管时间表方面存在差异。

介绍推动胶囊内视镜市场创新和策略合作的关键产业领导者。

产业领导企业正透过融合技术实力和策略伙伴关係关係来提升胶囊内视镜的临床效用，从而实现差异化竞争。大型跨国公司正大力投资于改进高解析度成像技术和延长电池寿命，并与研究机构合作，在同行评审期刊上发表研究成果以检验其发现。这些合作关係能够快速改善即时资料传输和位置感测器整合等设计功能，从而提高检查效率和诊断准确性。

为产业领导者提供切实可行的建议，以加强其技术采用、营运效率、监管合规性和市场定位策略。

产业领导者应优先考虑将人工智慧功能整合到胶囊内视镜平台中，以提高病灶检测准确率并缩短影像解读时间。透过整合能够自动标记异常的机器学习演算法，製造商可以提供全面的诊断工作流程，从而减轻临床医生的负担并加快患者照护过程。同时，投资于模组化设计原则和灵活的生产结构将有助于企业适应不断变化的法规环境并最大限度地降低供应链风险。

概述了为确保对行业趋势、数据来源检验和胶囊内视镜市场进行全面分析而采用的调查方法。

本研究结合了对同行评审期刊、监管文件和临床试验资料库的系统性回顾，以及对顶尖胃肠病学家、医疗设备工程师和采购专家的深入访谈。严谨的资讯来源检验确保了定性研究结果在多个资料点上得到交叉检验，从而提高了新兴趋势分析的可靠性。二级资讯来源包括医学协会发布的白皮书和监管机构发布的指南，这些资料为评估核准时间表和上市后监测要求提供了框架。

胶囊内视镜在现代胃肠道诊断中的演变、整合和未来前景的总结性观点。

随着胶囊内视镜技术的不断发展，其对胃肠道诊断的变革性影响日益显着。从超高解析度成像技术的进步到与远距远端医疗平台无缝整合的数据整合，这些口服型设备正在重塑临床医生的工作流程和患者的就医体验。监管政策的调整和合作研究倡议正在加速创新週期，推动从一次性胶囊向利用人工智慧和先进感测器技术的智慧系统转型。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 胶囊内视镜市场：依产品类型划分

  • 结肠胶囊内视镜检查
  • 食道胶囊内视镜
  • 小肠胶囊内视镜检查

第九章 依内视镜模式分類的胶囊内视镜市场

  • 可重复使用的胶囊
  • 免洗胶囊

第十章：胶囊内视镜市场：依年龄组别划分

  • 成人版
  • 老年人
  • 儿童

第十一章 胶囊内视镜市场：依应用领域划分

  • 乳糜泻
  • 大肠直肠癌筛检
  • 克隆氏症
  • 胃食道逆流症
  • 不明原因消化道出血（OGIB）
  • 小肠肿瘤
  • 溃疡检测

第十二章 胶囊内视镜市场：依通路划分

  • 离线
  • 在线的

第十三章 胶囊内视镜市场：依最终用户划分

  • 门诊手术中心（ASC）
  • 诊断中心
  • 医院
  • 研究机构

第十四章 胶囊内视镜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 胶囊内视镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 胶囊内视镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国胶囊内视镜市场

第十八章：中国胶囊内视镜市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advin Health Care
  • Anx Robotica Corp.
  • Beijing Richen-Force Science & Technology Co.,Ltd
  • Biocam Sp. z oo
  • CapsoVision, Inc.
  • Covestro AG
  • Duomed Group
  • Fujifilm Holding Corporation
  • Intromedic co., Ltd
  • JINSHAN Science & Technology（Group）Co., Ltd.
  • Medtronic PLC
  • MU Ltd.
  • Olympus Corporation
  • RF Systems Lab
  • Shangxian Minimal Invasive Inc
  • STERIS
  • SynMed Ltd.
Product Code: MRR-3A2E844FDE44

The Capsule Endoscopy Market was valued at USD 541.09 million in 2025 and is projected to grow to USD 583.89 million in 2026, with a CAGR of 8.28%, reaching USD 944.49 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 541.09 million
Estimated Year [2026] USD 583.89 million
Forecast Year [2032] USD 944.49 million
CAGR (%) 8.28%

Exploring the Transformative Role of Capsule Endoscopy Technologies in Redefining Noninvasive Gastrointestinal Diagnostics for Enhanced Patient Outcomes

Capsule endoscopy represents a landmark innovation in gastrointestinal diagnostics by replacing traditional invasive endoscopic procedures with a single swallowable device. The discreet nature of the capsule, equipped with high-definition imaging sensors, offers clinicians unrivaled access to deep sections of the small intestine that were previously challenging to visualize. As a result, patients experience reduced discomfort and risk compared to conventional endoscopy, fostering higher compliance rates among individuals requiring regular gastrointestinal assessment.

Initial trials and subsequent clinical adoption have underscored the value of this technology in detecting a spectrum of conditions, ranging from obscure gastrointestinal bleeding to suspected small intestine tumors. Enhanced illumination systems and expanded battery life have significantly increased the diagnostic yield, allowing longer transit durations and continuous image capture throughout the digestive tract. Coupled with wireless data acquisition platforms, these improvements have streamlined workflow for medical teams while offering real-time insights into patient health.

Looking ahead, ongoing research is focused on integrating advanced analytics and artificial intelligence into the capsule endoscopy framework. By leveraging machine learning algorithms to flag potential anomalies and cross-reference patient histories, the next generation of capsule endoscopy promises both heightened accuracy and accelerated reporting. This evolution underscores the critical role of capsule endoscopy in shaping future standards for noninvasive gastrointestinal care

Identifying Major Technological and Regulatory Shifts Shaping the Capsule Endoscopy Landscape and Driving Innovation in Gastrointestinal Imaging Worldwide

Technological breakthroughs have catalyzed an unparalleled transformation in the capsule endoscopy landscape, blurring the lines between diagnostics and data-driven decision making. Recent introductions of ultra-high-resolution imaging chips have delivered unprecedented clarity, enabling the detection of minute mucosal lesions that would have previously gone unnoticed. Meanwhile, advancements in power management have extended capsule battery life, permitting extended transit through the gastrointestinal tract and ensuring comprehensive visualization from the esophagus to the colon.

Simultaneously, regulatory frameworks have evolved to accommodate the growing complexity of ingestible diagnostic devices. Medical agencies across key markets have introduced expedited pathways for novel capsule designs and enhanced post-market surveillance protocols. These regulatory shifts have encouraged manufacturers to innovate aggressively while maintaining rigorous safety and efficacy standards. Consequently, the market has witnessed a surge in clinical collaborations aimed at validating new imaging modalities, including optical coherence tomography and hyperspectral analysis, within a capsule format.

In parallel, the convergence of telemedicine platforms and remote patient monitoring tools has redefined the patient experience. Physicians can now review capsule imagery in real time, and patients benefit from streamlined pre-procedure instructions and post-procedure consultations without in-person visits. These transformative shifts underscore an industry moving rapidly toward integrated care models, where capsule endoscopy functions not only as a diagnostic instrument but also as a key element in a broader digital health ecosystem

Evaluating the Cumulative Effects of the 2025 United States Tariff Adjustments on Global Capsule Endoscopy Supply Chains and Market Dynamics

In 2025, the imposition of updated United States tariffs has introduced a new set of challenges for the capsule endoscopy supply chain, prompting stakeholders to reevaluate sourcing strategies and cost structures. Historically reliant on components imported from major manufacturing hubs, device producers are now navigating elevated duties on specialized imaging sensors, microbattery units, and wireless transmission modules. As a result, production costs have risen, compelling manufacturers to explore alternative suppliers and form strategic partnerships to mitigate tariff-induced price pressures.

Moreover, these tariff adjustments have created ripple effects across distribution networks, with importers and healthcare providers facing higher acquisition expenses. Many hospitals and diagnostic centers have responded by renegotiating procurement agreements and seeking volume-based pricing arrangements to preserve budgetary margins. In tandem, suppliers are investing in domestic assembly capabilities and localized manufacturing initiatives to offset the financial impact of cross-border trade barriers. These activities have fostered greater supply chain resilience and have accelerated the implementation of nearshore production models.

Looking forward, industry participants are also advocating for policy dialogues to balance trade objectives with healthcare affordability. While tariffs aim to bolster domestic industrial growth, the ultimate concern remains the accessibility and pricing of life-saving diagnostic technologies. Stakeholders are therefore engaging with policymakers and trade associations to ensure that tariff frameworks evolve in a manner that sustains innovation while protecting patient access to advanced gastrointestinal diagnostics

Unveiling Critical Segmentation Insights for Product Variants Endoscopy Modes Age Groups Clinical Applications Distribution Channels and End User Categories

An in-depth segmentation analysis reveals distinct patterns in how different product configurations and clinical contexts shape market uptake. For instance, colon capsule endoscopy systems have gained prominence due to their targeted design for colorectal evaluation, while esophageal and small bowel platforms address specialized diagnostic scenarios. Each product tier demonstrates unique performance attributes, from capsule dimensions optimized for esophageal transit to advanced optical coatings engineered for small-bowel imaging.

Equally important is the differentiation by endoscopy mode, where reusable capsules are preferred for high-volume diagnostic centers seeking cost efficiencies, and single-use models appeal to institutions prioritizing sterility and patient safety. Age demographics further refine this picture, with adult patients representing the core user base, geriatric cohorts demanding minimally invasive options due to comorbidities, and pediatric applications driving innovation in capsule miniaturization.

Clinical applications present another layer of granularity, as the technology is employed for celiac disease monitoring, colon cancer screening, Crohn's disease assessment, gastroesophageal reflux evaluation, obscure gastrointestinal bleeding investigation, small intestine tumor detection, and precise ulcer identification. Distribution channels vary from established offline networks encompassing medical device distributors to emerging online portals that facilitate direct procurement. Finally, end users span ambulatory surgical centers seeking streamlined workflows, diagnostic centers focused on outpatient throughput, hospitals integrating capsule endoscopy into broader GI service lines, and research institutes exploring next-generation functionalities

Highlighting Regional Dynamics and Growth Drivers for Capsule Endoscopy Adoption across the Americas Europe Middle East Africa and Asia Pacific Markets

Across the Americas, particularly in North American markets, investment in gastrointestinal diagnostic infrastructure has accelerated the adoption of capsule endoscopy as a preferred noninvasive option. Favorable reimbursement policies and a high prevalence of colorectal cancer screening programs have driven clinicians to incorporate capsule systems into routine protocols. In Latin America, growing healthcare budgets and public health initiatives are fostering incremental uptake, although cost considerations and regulatory timelines vary by country.

Within Europe, the Middle East and Africa region, heterogeneous reimbursement landscapes pose both opportunities and challenges. Western European nations benefit from well-established reimbursement codes and robust clinical guidelines, which have enabled consistent integration of capsule endoscopy into gastroenterology practices. Conversely, parts of the Middle East are characterized by rapid modernization of healthcare facilities, leading to significant adoption surges in urban centers, while certain African markets remain constrained by limited specialist availability and infrastructure gaps.

The Asia-Pacific market exhibits dynamic growth driven by expanding healthcare access and rising awareness of digestive health issues. Countries such as Japan and South Korea, with advanced manufacturing capabilities and supportive regulatory frameworks, continue to lead in capsule endoscopy innovation. Meanwhile, emerging economies in Southeast Asia and India are witnessing increased demand for cost-effective, noninvasive diagnostic modalities, fueled by public screening campaigns and telemedicine integration. These regional dynamics underscore the importance of tailored market entry and engagement strategies

Showcasing Key Industry Leaders Driving Innovation and Strategic Collaborations in the Evolving Capsule Endoscopy Market Landscape

Industry leaders have distinguished themselves through a blend of technological prowess and strategic partnerships aimed at advancing the clinical utility of capsule endoscopy. Major multinational corporations have invested heavily in high-definition imaging enhancements and extended battery solutions, collaborating with research institutions to validate their contributions in peer-reviewed studies. These alliances have enabled rapid iteration of design features, such as real-time data transmission and integrated localization sensors, which enhance procedural efficiency and diagnostic accuracy.

Mid-tier manufacturers have likewise carved out specialized niches by focusing on cost-effective capsule platforms optimized for specific clinical segments, including pediatric applications and outpatient screening programs. These companies often leverage modular production frameworks to respond swiftly to evolving regulatory requirements and customer feedback. Collaborative agreements with hospitals and diagnostic clinics have facilitated field trials, enabling iterative refinement of software algorithms that support lesion detection and report generation.

In addition to hardware innovation, several key players have formed ecosystem partnerships with telehealth providers and cloud service operators to deliver end-to-end diagnostic solutions. This trend underscores a shift toward value-based care models, where capsule endoscopy emerges as a central component of integrated gastrointestinal health management. Collectively, these strategic activities reflect a competitive landscape where agility, clinical validation, and cross-sector collaborations define market leadership

Actionable Recommendations for Industry Leaders to Enhance Technological Adoption Operational Efficiency Regulatory Compliance and Market Positioning Strategies

Industry leaders should prioritize the integration of artificial intelligence capabilities into their capsule endoscopy platforms to enhance lesion detection accuracy and reduce interpretation times. By embedding machine learning algorithms capable of automated anomaly flagging, manufacturers can offer comprehensive diagnostic workflows that alleviate clinician burden and expedite patient care pathways. In parallel, investment in modular design principles and flexible manufacturing arrangements will help companies navigate evolving regulatory environments and minimize supply chain vulnerabilities.

Strategic partnerships with both domestic and nearshore component suppliers can mitigate the financial impact of cross-border tariffs while supporting more resilient production networks. Engaging proactively with regulatory agencies to secure expedited review pathways will further accelerate time-to-market for next-generation systems. In terms of market expansion, targeting emerging regions through customized reimbursement models and training programs can unlock new user bases, particularly in underserved areas where gastrointestinal conditions impose significant healthcare burdens.

Finally, healthcare providers and device developers alike should cultivate collaborative networks with telemedicine and digital health service providers. Offering integrated diagnostic packages that combine capsule endoscopy with remote patient monitoring and virtual follow-up consultations will align with broader value-based care initiatives. These actionable strategies will empower stakeholders to optimize diagnostic performance, reinforce market positioning, and deliver superior patient outcomes

Outlining the Research Methodology Employed to Capture Industry Trends Validate Data Sources and Ensure Thorough Analysis of Capsule Endoscopy Market Insights

This research effort combined a systematic review of peer-reviewed journals, regulatory filings, and clinical trial databases with in-depth interviews conducted with leading gastroenterologists, device engineers, and procurement specialists. Rigorous source triangulation ensured that qualitative insights were cross-validated against multiple data points, enhancing the reliability of emerging trend analysis. Secondary sources included white papers from professional medical societies and guidelines published by regulatory agencies, which provided a framework for assessing approval timelines and post-market surveillance requirements.

Primary research involved structured discussions with senior clinicians who have pioneered capsule endoscopy adoption in diverse clinical settings, alongside conversations with technical experts responsible for device design and integration. Feedback from procurement teams across ambulatory centers and hospitals shed light on distribution channel dynamics and purchasing decision criteria. All insights were synthesized through a multi-stage analytical process, which encompassed thematic coding to identify core drivers, barriers, and innovation hotspots. These findings were then subjected to peer review by an experienced advisory panel to ensure comprehensive coverage and unbiased interpretation. Through this methodology, the study delivers a robust and nuanced understanding of the capsule endoscopy ecosystem

Drawing Conclusive Perspectives on the Evolution Integration and Future Outlook of Capsule Endoscopy in Modern Gastrointestinal Diagnostics

As capsule endoscopy technologies continue to evolve, their transformative impact on gastrointestinal diagnostics is becoming increasingly evident. From ultra-high-resolution imaging enhancements to seamless data integration within telehealth platforms, these ingestible devices are redefining clinician workflows and patient experiences alike. Regulatory adaptations and collaborative research initiatives have accelerated innovation cycles, driving the transition from single-use capsules toward intelligent systems powered by artificial intelligence and advanced sensor modalities.

The cumulative effect of U.S. tariff adjustments in 2025 highlights the importance of resilient supply chain strategies and nearshore manufacturing capabilities. Meanwhile, segmentation analysis underscores distinct preferences among clinical applications, age groups, and endoscopy modes, offering manufacturers opportunities to tailor solutions to specific market niches. Regional dynamics in the Americas, EMEA, and Asia-Pacific further illustrate the necessity of localized approaches that consider reimbursement landscapes, infrastructure maturity, and patient awareness levels.

Looking ahead, stakeholders who embrace modular design, foster strategic ecosystem partnerships, and prioritize regulatory alignment will be best positioned to capture the next wave of growth. The evolution of capsule endoscopy is not simply a technological journey, but a paradigm shift toward patient-centric, data-driven healthcare. As this field matures, it will play an integral role in holistic gastrointestinal care pathways, empowering clinicians with tools that deliver precision, efficiency, and enhanced patient outcomes

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capsule Endoscopy Market, by Product Type

  • 8.1. Colon Capsule Endoscopy
  • 8.2. Esophageal Capsule Endoscopy
  • 8.3. Small Bowel Capsule Endoscopy

9. Capsule Endoscopy Market, by Endoscopy Mode

  • 9.1. Reusable Capsules
  • 9.2. Single Use Capsules

10. Capsule Endoscopy Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Capsule Endoscopy Market, by Application

  • 11.1. Celiac Disease
  • 11.2. Colon Cancer Screening
  • 11.3. Crohn's Disease
  • 11.4. Gastroesophageal Reflux Disease
  • 11.5. Obscure Gastrointestinal Bleeding (OGIB)
  • 11.6. Small Intestine Tumors
  • 11.7. Ulcer Detection

12. Capsule Endoscopy Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Capsule Endoscopy Market, by End User

  • 13.1. Ambulatory Surgical Centers (ASCs)
  • 13.2. Diagnostic Centers
  • 13.3. Hospitals
  • 13.4. Research Institutes

14. Capsule Endoscopy Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Capsule Endoscopy Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Capsule Endoscopy Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Capsule Endoscopy Market

18. China Capsule Endoscopy Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Advin Health Care
  • 19.6. Anx Robotica Corp.
  • 19.7. Beijing Richen-Force Science & Technology Co.,Ltd
  • 19.8. Biocam Sp. z o.o.
  • 19.9. CapsoVision, Inc.
  • 19.10. Covestro AG
  • 19.11. Duomed Group
  • 19.12. Fujifilm Holding Corporation
  • 19.13. Intromedic co., Ltd
  • 19.14. JINSHAN Science & Technology (Group) Co., Ltd.
  • 19.15. Medtronic PLC
  • 19.16. MU Ltd.
  • 19.17. Olympus Corporation
  • 19.18. RF Systems Lab
  • 19.19. Shangxian Minimal Invasive Inc
  • 19.20. STERIS
  • 19.21. SynMed Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPSULE ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPSULE ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ESOPHAGEAL CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL BOWEL CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REUSABLE CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SINGLE USE CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CELIAC DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COLON CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OBSCURE GASTROINTESTINAL BLEEDING (OGIB), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY SMALL INTESTINE TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ULCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY ENDOSCOPY MODE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)